Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Hum Rep 2011;26 11811190
Safety Profile & Considerations Current understanding suggests: Generally well-tolerated in research settings No significant toxicity signals in preclinical studies Does not appear to suppress immune function However: Not approved for veterinary use Limited large-scale clinical trials in animals Should only be considered under qualified veterinary supervision What Veterinarians Are Observing In integrative and regenerative veterinary settings, BPC-157 is being explored as part of broader healing protocols
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Phase 1 clinical trial of Trametes versicolor in women with breast cancer
Effective April 22, 2026, BPC-157 was removed from Category 2 (the bulks substances list flagged as raising significant safety concerns)
C.KainzA.WolfM.RedonJ.OberbauerR
)
US$ 23.14
US$ 25.89
US$ 23.03
US$ 22.69
US$ 25.24
